INTRODUCTION
Descemet membrane endothelial keratoplasty (DMEK) is an attractive alternative to corneal transplantation for patients with endothelial dysfunction. The procedure involves transplantation of a graft consisting of donor endothelium and Descemet membrane (DM) that replaces the host endothelium and DM. This procedure offers certain advantages over Descemet stripping (automated) endothelial keratoplasty (DS(A)EK) in which the graft includes portions of stromal tissue that may distort the corneal architecture, produce more higher-order aberrations, and provide more immunogenic tissue that could possibly precipitate graft rejection(1-5). Although DMEK has been shown to have quicker and more pronounced visual rehabilitation than DSEK(1), the different techniques and learning curve of DMEK have limited widespread adoption of this approach.
One of the most important challenges facing DMEK is preventing postoperative graft detachment, which is the most frequent complication of the procedure. Detachment rates reported in the literature vary, with one recent multicenter study reporting rates of 34.6%(6). These detachments may necessitate postoperative intervention involving reinjection of intraocular air.
Although some surgeons use air for tamponade during the procedure, longer-acting inert gases, such as sulfur hexafluoride (SF6), have been explored for this application recently. SF6 has a higher buoyancy and a longer half-life than those of air(7), which possibly provides advantages for maintaining graft attachment postoperatively. A recent study of 44 patients who underwent DSEK compared SF6 with air for graft attachment and noted that, although patients who received air had five graft detachments, there were no detachments reported in the group that received SF6 (8). Additionally, Guell et al., recently demonstrated reduced detachment rates with SF6 from those with air in their series, and no effect on corneal endothelial cell counts was observed(9). In the present study, we compared graft detachment rates between SF6 and air for intraocular tamponade in DMEK.
METHODS
A retrospective chart review was performed to evaluate patients who underwent DMEK by a single surgeon (A.S.J.) at the Wilmer Eye Institute of Johns Hopkins Hospital between January 2012 and December 2014. Forty-two eyes were identified; 21 received air for intraocular tamponade and 21 received SF6. Approval from the Institutional Review Board of Johns Hopkins University was obtained, and the study was conducted in concordance with the ethical principles established in the Declaration of Helsinki.
Data on patient demographics, preoperative and postoperative intraocular pressure (IOP), best spectacle corrected visual acuity (BSCVA), graft detachment, and donor tissue were collected from the patients' operative and follow-up notes and from tissue bank information. BSCVA was measured using the Snellen chart, and IOP was measured using Goldmann applanation tonometry. The indication for all operations was bullous keratopathy caused by Fuchs' endothelial dystrophy.
Surgical procedure
Operations were performed under sub-Tenon anesthesia by a single surgeon (A.S.J.). Initial steps of the procedure were performed by making a 2.75-mm clear corneal keratome incision and included scoring of the DM at the same size as the planned graft, removal of the DM, and scraping of the peripheral recipient stromal bed. All patients underwent an intraoperative inferior peripheral iridectomy. In 32 of the 42 cases, combined phacoemulsification with intraocular lens (IOL) implantation was performed before any steps of the DMEK procedure.
Sterile 20% SF6 gas mixed with air was prepared as follows: 100% filtered SF6 gas was drawn up from the tank into a syringe and diluted to 20% with filtered air. Using a stop-cock, the 20% SF6 gas was distributed into 1-cc syringes with capped 30-gauge intraocular cannulas.
Preparation and insertion of donor tissue was performed as previously described(10). In brief, standard intravenous tubing (part number MX451FL; Smiths Medical, Dublin, OH) was cut approximately 2 inches from the Luer lock and attached to an Alcon B IOL cartridge (Alcon, Fort Worth, TX). Trephination was performed on pre-dissected DMEK donor tissue obtained from Lions VisionGift (Portland, OR) with sizes ranging from 7.75 to 8.5 mm depending on the recipient's corneal size. Donor tissue was stained with trypan blue and placed into the IOL cartridge. After the graft was inserted and unfolded, the eye was completely filled with either air or a 20% SF6 mixture. Following a 10-minute waiting period, a small amount of gas was released to reduce the IOP to approximately 10-20 mmHg by palpation. The patient was then discharged home and instructed to remain in the supine position as follows: for air, the supine period was continuous until 6 pm on postoperative day 2 and included 10-minute upright periods hourly while awake and every 2 hours overnight on the night of surgery only; for SF6, the supine period was continuous for the day of surgery and postoperative day 1 and included 10-minute upright periods hourly while awake and every 2-3 hours overnight on the night of surgery and the next night. For postoperative days 2 and 3, 2 hours of supine positioning were interspersed with 1 hour of upright light activity and no overnight positioning, and for postoperative days 4 and 5, 2 hours of supine positioning were interspersed with 2 hours of upright light activity and no overnight positioning. Starting at the postoperative day 1 visit, standard postoperative topical corticosteroids and antibiotics were applied to the operated eye.
Follow-up
The patients' follow-up information was obtained at 1 day, 1 week, and 1 month postoperatively. BSCVA measurements postsurgically were taken from approximately 6 months after intervention (range, 4-7 months). No complete graft detachments occurred, and all partial detachments identified in data collection underwent intervention with reinjection of intraocular air.
Statistical analyses
Analyses using the two-tailed Student's t-test and chi-squared tests were performed. Additionally, we performed univariate and multivariate analyses to evaluate the association between measured variables and graft detachment rates. Analyses were performed in the R statistical computing environment using the glm() function with the option, "family='binomial'." P<0.05 was considered to indicate statistical significance.
RESULTS
Forty-two eyes were included; 21 received air and the next 21 consecutive eyes received SF6 for intraocular tamponade. Table 1 summarizes the baseline characteristics for each group. The preoperative BSCVA values were significantly different between the two groups (Group 1 (air): logMAR, 0.33 ± 0.15; Group 2 (SF6): logMAR, 0.48 ± 0.21 (p=0.014), with no significant differences in the other preoperative measures.
Table 1 Baseline characteristics
Group 1 (air) | Group 2 (SF6) | |
---|---|---|
No of eyes/patients | 21/17 | 21/16 |
Age (years) | ||
(Mean ± SD) | 62.90 ± 7.50 | 63.50 ± 5.60 |
Sex | ||
(% male) | 29% | 25% |
(% female) | 71% | 75% |
Preoperative BSCVA (logMAR) | ||
(Mean ± SD) | 0.33 ± 0.15 | 0.48 ± 0.21† |
Donor age | ||
(Mean ± SD) | 68.70 ± 4.80 | 65.70 ± 5.80 |
Donor endothelial cell count | ||
(Mean ± SD) | 2852 ± 239 | 2808 ± 401 |
Death to transplant (days) | ||
(Mean ± SD) | 4.30 ± 1.10 | 4.60 ± 1.60 |
†p<0.05= for all other baseline characteristics; p>0.05.
For other ocular comorbidities, one patient in group 1 had diabetic macular edema, one patient in group 1 had epiretinal membranes in both eyes, one in group 1 had a history of optic neuritis, two patients in group 2 were glaucoma suspects, and one patient in group 2 had mild amblyopia OS.
Operative characteristics
Table 2 summarizes operative measurements and information. Eighty-six percent of the air cases were combined with CE/IOL, and 67% of the SF6 cases were combined with CE/IOL. There was a significant difference in graft size between the groups (group 1, 8.4 ± 0.2 mm; group 2, 8.1 ± 0.2 mm (p=0.000010).
Table 2 Surgical outcomes
Group 1 (air) |
Group 2 (SF 6) |
p-value (Group 1 vs. Group 2) |
|
---|---|---|---|
Combined with CE/IOL | |||
(%) | 86 | 67 | 0.150000 |
Post-op BSCVA (logMAR) | |||
(Mean ± SD) | 0.10 ± 0.12 | 0.09 ± 0.10 | 0.900000 |
Graft Size (mm) | |||
(Mean ± SD) | 8.40 ± 0.20 | 8.10 ± 0.20 | 0.000010 |
Detachment rate | |||
(%) | 67 | 19 | 0.002000 |
Pre-op IOP | |||
(Mean ± SD) | 13.10 ± 3.20 | 14.50 ± 3.10 | 0.160000 |
IOP POD#1 | |||
(Mean ± SD) | 18.80 ± 9.50 | 16.40 ± 4.00 | 0.300000 |
Visual outcomes
The mean change in BSCVA was -0.24 ± 0.19 inches in group 1 and -0.39 ± 0.17 inches in group 2 (p=0.011). However, there was no significant difference in the percentages of eyes with 20/25 or better BSCVA between the groups (67% vs. 71%).
Graft detachment rate
No complete graft detachments occurred. Intervention involving reinjection of intraocular air occurred in 67% of the eyes in group 1 (air) and in 19% in group 2 (SF6) (p=0.0020). All cases of partial detachment were deemed appropriate for reinjection of air.
Other complications
There was one case of pupillary block in group 1 on postoperative day 1 and one occurrence in group 2 on postoperative day 2. There was no significant difference in IOPs on the first day between the groups (Table 2). No graft rejections or failures were noted.
In univariate analysis (Table 3), the gas used was the most significant factor predicting graft detachment (odds ratio, 8.50; p=0.0031). Graft size was also significant (odds ratio, 14.96; p=0.043).
Table 3 Univariate analysis of effect on graft detachment rate
Odds ratio | LCB† | UCB‡ | p-value | |
---|---|---|---|---|
Patient age | 0.98 | 0.89 | 1.08 | 0.6900 |
Patient sex | 1.50 | 0.39 | 5.77 | 0.5600 |
IOP Pre-op | 0.81 | 0.65 | 1.00 | 0.0560 |
Pre-op BSCVA | 0.07 | 0.00 | 2.46 | 0.1400 |
Change VA | 9.12 | 0.30 | 278.31 | 0.2000 |
Gas used | 8.50 | 2.06 | 35.08 | 0.0031 |
Graft size (mm) | 14.96 | 1.09 | 205.56 | 0.0430 |
Death to transplant (days) | 1.02 | 0.66 | 1.59 | 0.9200 |
Pre-op endothelial cell density | 1.00 | 1.00 | 1.00 | 0.8100 |
†LCB= lower border of 95% confidence interval;
‡UCB= upper border of 95% confidence interval.
In multivariate analysis (Table 4) with gas included but not graft size, gas remained an independent statistically significant predictor of detachment (air: OR, 6.65; p=0.020). When graft size was included as a covariate, gas was no longer a statistically significant predictor of detachment but maintained OR of 7.81 (p=0.063), similar to results of univariate and multivariate analyses without graft size. No other factor in this analysis was significant.
Table 4 Effect of air on detachment rate determined by multivariate analysis with and without graft size included
Odds ratio | LCB† | UCB‡ | P-value | |
---|---|---|---|---|
Graft size excluded | ||||
Gas used (Air) | 6.65 | 1.35 | 32.83 | 0.020 |
Graft Size Included | ||||
Gas used (Air) | 7.81 | 0.90 | 67.95 | 0.063 |
Graft size | 0.60 | 0.01 | 60.66 | 0.830 |
†LCB= lower border of 95% confidence interval;
‡UCB= upper border of 95% confidence interval. No other factors from univariate analysis were statistically significant on multivariate analysis.
DISCUSSION
In this study, we compared the outcomes of 42 eyes that underwent DMEK at our institution, 21 with 20% SF6 and 21 with 100% air used for intraocular tamponade, and focused on detachment and intervention rates. We demonstrated a lower detachment rate when SF6 was used, and no significant differences in other outcome measures were observed.
Complication rates with DMEK have improved over the years with refinements in surgical technique and increased surgical experience. Graft detachment rates have dramatically improved. An important criterion to consider, however, is the surgeon's determination of which detachments require intervention. A recent series by Terry using SF6 for DMEK demonstrated a 6% graft rebubbling rate, although a 47% graft detachment rate as measured by optical coherence tomography (OCT) was reported (11). Their rebubbling criteria were separation of donor Descemet membrane causing central corneal edema affecting vision and/or evidence of progressive separation of the graft over successive visits. Guell et al. noticed a similar rebubbling rate but stated that they also had detachments that did not fit their criteria for rebubbling(9). In our study, all of the partial graft detachments were determined to fit our criteria for rebubbling, which included central corneal edema affecting vision. There are limited data on whether more aggressive intervention is necessary or beneficial to long-term vision recovery, and currently the decision to intervene is at the surgeon's discretion.
In our experience, the incorporation of SF6 coincided with the transition to smaller trephine size (8.0 mm). Both smaller trephine size and use of SF6 correlated with reduced risk of detachment in the univariate analysis (Table 3). Multivariate analysis with both variables included was, therefore, partially confounded. However, comparison of the detachment rates between eyes with the same graft size but that had received SF6 or air suggests a benefit for the former. For example, 8.5-mm grafts showed detachments rates of 68% for group 1 (13/19) and 20% for group 2 (1/5). For graft sizes of ≤8.0 mm, the detachment rates were 50% for group 1 (1/2) and 19% for group 2 (3/16). However, the coinciding changes in smaller graft size from 8.5 to 8.0 mm with the introduction of SF6 led to only two eyes in our series receiving both 8.0-mm graft size and air, which made a more robust analysis difficult. The high odds ratio for reduced detachment rate with SF6 use and the significance from univariate and multivariate analyses with graft size removed strongly suggest that the gas used is a significant factor affecting detachment rate. Additionally, the gas used had a much more statistically significant effect than did graft size when both were included in the multivariate model. However, because our study design was retrospective, and changes in graft size coincided with the change from air to SF6, our analysis could not determine the relative contribution of these two factors.
An additional concern with use of SF6 is potential toxicity to the corneal endothelium(12). Although the gas is thought to be inert, increased buoyancy and longevity of the gas may have mechanical effects on the endothelial surface(13). A recent in vitro study, however, found no significant difference between SF6 and air on endothelial cell counts or toxicity of corneal endothelial cells(14). Additionally, Guell et al. found no difference in endothelial cell counts between use of SF6 or air ≤3years after DMEK(9).
One weakness of our study was that the SF6 procedures followed the air procedures chronologically because detachment rates have been found to diminish with experience of the surgeon(15). However, the reduction in detachment rates from the first 21 to the next 21 consecutive eyes was dramatic, and detachment rates were equivalent between those in the first half of air cases and those in the second half. Although technical improvement of the surgeon may account for some of this difference, SF6 was found to have a substantial impact on maintaining graft adherence and preventing graft detachment post-surgery without any significant differences in other outcome measures in our study. Randomized prospective studies could further address this important question.